FDA Says Found Possible Carcinogen in Certain Samples of Merck's Januvia
The Food and Drug Administration said on Tuesday certain samples of sitagliptin, a compound in Merck's diabetes drug Januvia, were contaminated with a possible carcinogen.
Reuters Health Information
source https://www.medscape.com/viewarticle/978953?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/978953?src=rss
Comments
Post a Comment